Market Cap 3.78B
Revenue (ttm) 401.20M
Net Income (ttm) -283.01M
EPS (ttm) N/A
PE Ratio 47.53
Forward PE 48.97
Profit Margin -70.54%
Debt to Equity Ratio 0.00
Volume 1,663,900
Avg Vol 1,835,398
Day's Range N/A - N/A
Shares Out 239.47M
Stochastic %K 87%
Beta 1.27
Analysts Strong Sell
Price Target $22.57

Company Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to access, collect, review, extract, decode, decrypt, analyze, share, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime,...

Industry: Software - Infrastructure
Sector: Technology
Phone: 972 73 394 8000
Fax: 972 3 924 7104
Address:
94 Shlomo Shmelzer Road, P.O.B 3925, Petah Tikva, Israel
jacksonjohn750
jacksonjohn750 Aug. 22 at 2:31 PM
$CLBT let's go!
0 · Reply
Pumlitch
Pumlitch Aug. 22 at 7:48 AM
A few nice charts from my watch list. $AROC $NU $CLBT $RDNT
0 · Reply
InvestorWisdom
InvestorWisdom Aug. 22 at 3:46 AM
Interesting day. IWM was up while the SPY was down. Small caps showing some relative strength. $LENZ $CLBT $AXSM $FROG and others closed at or near the high of the day and look like they want to move higher…. Although tomorrow could be rocky with Powell’s speech. $INSM is not a small cap, but it closed at the high and continues to be a market leader. I wouldn’t be surprised if this trends higher and higher for months. No matter what the over market is doing its trading with its own purpose. This new drug is attracting new institutional money to the stock… Theres significant growth potential considering they are still discovering new uses + it has little to no side effects. A “skeleton key” drug, per the CEO… If it unexpectedly dips, I will rebuy options to add to my long shares. I had to take profits on my calls because they expired on Friday and the premium is too high right now to replace them, but I did very well from the high tight flag breakout
0 · Reply
InvestorWisdom
InvestorWisdom Aug. 21 at 4:04 PM
$CLBT tested the 10EMA this AM and now at a new daily high…
0 · Reply
punktdot
punktdot Aug. 21 at 1:50 PM
$CLBT why cant this just keep at least some of the gains?
2 · Reply
Ej_kyy08
Ej_kyy08 Aug. 21 at 10:03 AM
$CLBT With increasing revenue and with positive earning per share, new ceo, i didnt even see a dilution this quarter means its already stopped. And with doj fed ramp and the acquisition of correlium with good synergy. I dont see any good competitor in their niche which is a digital intelligence solution and its almost like a moat. With all of these I do see the the price will double from its floor price of 13.5 within 2 or even a year. Its a complete turn around. Goodluck to us
0 · Reply
macroaxis
macroaxis Aug. 20 at 10:50 PM
$CLBT – Volatility Alert: Rising Pin Risk in Cellebrite Options – Investors Should Watch Closely https://www.macroaxis.com/stock-options/CLBT/Cellebrite-DI?utm_source=dlvr.it&utm_medium=stocktwits
1 · Reply
Blaze_Equity
Blaze_Equity Aug. 18 at 9:19 PM
$CLBT yessir
0 · Reply
topstockalerts
topstockalerts Aug. 18 at 7:15 PM
$CLBT let’s see that bounce.......
0 · Reply
1papainversor
1papainversor Aug. 18 at 6:25 PM
$CLBT One thing I’ve learned: price follows FCF per share
0 · Reply
Latest News on CLBT
Cellebrite DI Ltd. (CLBT) Q2 2025 Earnings Call Transcript

Aug 14, 2025, 1:24 PM EDT - 8 days ago

Cellebrite DI Ltd. (CLBT) Q2 2025 Earnings Call Transcript


Cellebrite Announces Second-Quarter 2025 Results

Aug 14, 2025, 7:00 AM EDT - 8 days ago

Cellebrite Announces Second-Quarter 2025 Results


Cellebrite DI: Market Apathy Vs. Strong Fundamentals

Aug 13, 2025, 8:24 PM EDT - 9 days ago

Cellebrite DI: Market Apathy Vs. Strong Fundamentals


Cellebrite Names David Barter Chief Financial Officer

Jul 8, 2025, 8:30 AM EDT - 6 weeks ago

Cellebrite Names David Barter Chief Financial Officer


Cellebrite to Acquire Corellium

Jun 5, 2025, 7:30 AM EDT - 2 months ago

Cellebrite to Acquire Corellium


Greenhaven Road Capital Main Fund Q1 2025 Top 5 Holdings

May 19, 2025, 9:35 AM EDT - 3 months ago

Greenhaven Road Capital Main Fund Q1 2025 Top 5 Holdings

BUR KKR LFCR PAR


Cellebrite DI Ltd. (CLBT) Q1 2025 Earnings Call Transcript

May 14, 2025, 11:22 AM EDT - 3 months ago

Cellebrite DI Ltd. (CLBT) Q1 2025 Earnings Call Transcript


Cellebrite Announces First-Quarter 2025 Results

May 14, 2025, 7:00 AM EDT - 3 months ago

Cellebrite Announces First-Quarter 2025 Results


Cellebrite Files its 2024 Annual Report on Form 20-F

Mar 18, 2025, 9:00 AM EDT - 5 months ago

Cellebrite Files its 2024 Annual Report on Form 20-F


Cellebrite DI Ltd. (CLBT) Q4 2024 Earnings Call Transcript

Feb 13, 2025, 7:14 PM EST - 6 months ago

Cellebrite DI Ltd. (CLBT) Q4 2024 Earnings Call Transcript


Cellebrite Announces Fourth-Quarter and Full-Year 2024 Results

Feb 13, 2025, 7:00 AM EST - 6 months ago

Cellebrite Announces Fourth-Quarter and Full-Year 2024 Results


My Top 10 Stock Picks for 2025

Dec 27, 2024, 10:00 AM EST - 8 months ago

My Top 10 Stock Picks for 2025

ADBE CEG EWM HEI MGM SHOP UNH


Cellebrite: There Are Potential Risks That Could Damper Growth

Nov 8, 2024, 9:22 AM EST - 10 months ago

Cellebrite: There Are Potential Risks That Could Damper Growth


Cellebrite DI Ltd. (CLBT) Q3 2024 Earnings Call Transcript

Nov 6, 2024, 3:44 PM EST - 10 months ago

Cellebrite DI Ltd. (CLBT) Q3 2024 Earnings Call Transcript


CORRECTION: Cellebrite Announces Third-Quarter 2024 Results

Nov 6, 2024, 8:26 AM EST - 10 months ago

CORRECTION: Cellebrite Announces Third-Quarter 2024 Results


Yossi Carmil to Step Down as CEO After Nearly 20 Years

Nov 6, 2024, 8:20 AM EST - 10 months ago

Yossi Carmil to Step Down as CEO After Nearly 20 Years


Cellebrite: Rating Downgrade As Valuation Has Caught Up

Aug 26, 2024, 8:55 PM EDT - 1 year ago

Cellebrite: Rating Downgrade As Valuation Has Caught Up


Cellebrite DI Ltd. (CLBT) Q2 2024 Earnings Call Transcript

Aug 15, 2024, 8:52 PM EDT - 1 year ago

Cellebrite DI Ltd. (CLBT) Q2 2024 Earnings Call Transcript


Cellebrite Announces Second-Quarter 2024 Results

Aug 15, 2024, 7:05 AM EDT - 1 year ago

Cellebrite Announces Second-Quarter 2024 Results


Cellebrite Announces Redemption of All Outstanding Warrants

Aug 15, 2024, 7:00 AM EDT - 1 year ago

Cellebrite Announces Redemption of All Outstanding Warrants


Cellebrite DI Ltd. (CLBT) Q1 2024 Earnings Call Transcript

May 23, 2024, 3:09 PM EDT - 1 year ago

Cellebrite DI Ltd. (CLBT) Q1 2024 Earnings Call Transcript


Cellebrite Announces First-Quarter 2024 Results

May 23, 2024, 7:00 AM EDT - 1 year ago

Cellebrite Announces First-Quarter 2024 Results


Cellebrite: Big Fish In A Small Pond

Apr 29, 2024, 7:03 AM EDT - 1 year ago

Cellebrite: Big Fish In A Small Pond


jacksonjohn750
jacksonjohn750 Aug. 22 at 2:31 PM
$CLBT let's go!
0 · Reply
Pumlitch
Pumlitch Aug. 22 at 7:48 AM
A few nice charts from my watch list. $AROC $NU $CLBT $RDNT
0 · Reply
InvestorWisdom
InvestorWisdom Aug. 22 at 3:46 AM
Interesting day. IWM was up while the SPY was down. Small caps showing some relative strength. $LENZ $CLBT $AXSM $FROG and others closed at or near the high of the day and look like they want to move higher…. Although tomorrow could be rocky with Powell’s speech. $INSM is not a small cap, but it closed at the high and continues to be a market leader. I wouldn’t be surprised if this trends higher and higher for months. No matter what the over market is doing its trading with its own purpose. This new drug is attracting new institutional money to the stock… Theres significant growth potential considering they are still discovering new uses + it has little to no side effects. A “skeleton key” drug, per the CEO… If it unexpectedly dips, I will rebuy options to add to my long shares. I had to take profits on my calls because they expired on Friday and the premium is too high right now to replace them, but I did very well from the high tight flag breakout
0 · Reply
InvestorWisdom
InvestorWisdom Aug. 21 at 4:04 PM
$CLBT tested the 10EMA this AM and now at a new daily high…
0 · Reply
punktdot
punktdot Aug. 21 at 1:50 PM
$CLBT why cant this just keep at least some of the gains?
2 · Reply
Ej_kyy08
Ej_kyy08 Aug. 21 at 10:03 AM
$CLBT With increasing revenue and with positive earning per share, new ceo, i didnt even see a dilution this quarter means its already stopped. And with doj fed ramp and the acquisition of correlium with good synergy. I dont see any good competitor in their niche which is a digital intelligence solution and its almost like a moat. With all of these I do see the the price will double from its floor price of 13.5 within 2 or even a year. Its a complete turn around. Goodluck to us
0 · Reply
macroaxis
macroaxis Aug. 20 at 10:50 PM
$CLBT – Volatility Alert: Rising Pin Risk in Cellebrite Options – Investors Should Watch Closely https://www.macroaxis.com/stock-options/CLBT/Cellebrite-DI?utm_source=dlvr.it&utm_medium=stocktwits
1 · Reply
Blaze_Equity
Blaze_Equity Aug. 18 at 9:19 PM
$CLBT yessir
0 · Reply
topstockalerts
topstockalerts Aug. 18 at 7:15 PM
$CLBT let’s see that bounce.......
0 · Reply
1papainversor
1papainversor Aug. 18 at 6:25 PM
$CLBT One thing I’ve learned: price follows FCF per share
0 · Reply
jacksonjohn750
jacksonjohn750 Aug. 18 at 4:16 PM
$CLBT There it is... let's get back to 20!
0 · Reply
Winning_calls
Winning_calls Aug. 18 at 4:03 PM
$CLBT 👋👋
0 · Reply
Winning_calls
Winning_calls Aug. 18 at 3:02 PM
$CLBT 🤞🤞🤞
1 · Reply
punktdot
punktdot Aug. 18 at 1:20 PM
$CLBT we need a trend reversal, this has to rise $10+ to catch up
0 · Reply
CalculatedSwing
CalculatedSwing Aug. 18 at 12:22 PM
$CLBT check $GLMD OUT :) TML!
0 · Reply
Winning_calls
Winning_calls Aug. 18 at 3:18 AM
$CLBT pick me up @ $15.62
0 · Reply
KickRocksCapital
KickRocksCapital Aug. 16 at 1:10 PM
$CLBT BofA: $25 -> $24 Needham: $24 -> $18 Lake Street: $24 -> $22 Deutsche Bank: $24 -> $21 Avg $21. Deserved down adjustments due to H2 guidance reduction. I think the worst is behind. H2 is set up for easy beats. 2026 will be the year for the real gains. Hold through 2026!
1 · Reply
Tumbuffet40
Tumbuffet40 Aug. 16 at 6:42 AM
$CLBT omg I have listen the full webcast: insane! I have to write to investor relations and congratulate with them! It was literally a stellar performance! I am actually surprised that the analyst ratings haven t been upgraded to 28/30. It was one of the most bullish ER ever heard from them since SPAC merge. I love this new team! I liked how they replied to the analysts and I like the panel of analysts asking questions! Well well done!
0 · Reply
jacksonjohn750
jacksonjohn750 Aug. 15 at 6:38 PM
$CLBT let's get that 16
0 · Reply
DCRMIA
DCRMIA Aug. 15 at 1:11 PM
$CLBT "Lake Street Capital Markets maintains Cellebrite at ’buy’ with a price target of $22.000" https://www.investing.com/news/pro/lake-street-capital-markets-maintains-cellebrite-at-buy-with-a-price-target-of-22000-4195385
0 · Reply
ShKumaresan
ShKumaresan Aug. 15 at 11:56 AM
$SLE $WULF $CLBT Super League, Terawulf, Cellebrite Dominate Stocktwits Retail Chatter Among Tech Stocks: Find Out Why https://stocktwits.com/news-articles/markets/equity/super-league-terawulf-cellebrite/chsP84mRdfX
0 · Reply
StocktwitsNews
StocktwitsNews Aug. 15 at 11:55 AM
Super League, Terawulf, Cellebrite Dominate Stocktwits Retail Chatter Among Tech Stocks: Find Out Why $SLE $WULF $CLBT $QQQ https://stocktwits.com/news/equity/markets/super-league-terawulf-cellebrite/chsP84mRdfX
0 · Reply